IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,993,744 | -12.9% | 90,010 | -6.3% | 0.37% | -13.3% |
| Q2 2023 | $4,587,814 | +6.9% | 96,100 | -11.9% | 0.42% | +14.7% |
| Q1 2023 | $4,293,085 | +39.9% | 109,100 | +0.6% | 0.37% | +42.1% |
| Q4 2022 | $3,069,465 | -15.8% | 108,500 | -10.6% | 0.26% | -21.5% |
| Q3 2022 | $3,646,000 | -11.4% | 121,300 | 0.0% | 0.33% | 0.0% |
| Q2 2022 | $4,116,000 | -24.4% | 121,300 | -0.2% | 0.33% | -6.2% |
| Q1 2022 | $5,448,000 | -3.0% | 121,500 | 0.0% | 0.35% | -6.4% |
| Q4 2021 | $5,614,000 | +159.4% | 121,500 | +88.7% | 0.38% | +125.1% |
| Q3 2021 | $2,164,000 | +8223.1% | 64,400 | +9100.0% | 0.17% | +5466.7% |
| Q3 2018 | $26,000 | +36.8% | 700 | -22.2% | 0.00% | +50.0% |
| Q2 2018 | $19,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |